Net sales for 2020 were Dh581.2 million, which is a 93 per cent gain on 2019’s Dh301.5 million. Dr. Essam Farouk, CEO of Julphar, said in a statement: “We will consolidate our market position and expand our market share in the MENA region. The ongoing transformation programme will make the company more competitive in our core markets.
“Last year, the capital restructuring marked a major milestone in our transformation. We are confident that the company is well on track to regain its leading market position in the MENA region.”
Capital plans
Last year, Julphar’s board approved a special resolution for a capital reduction followed by a capital increase through a rights issue.
Related Keywords
China , Saudi Arabia , Dubai , Dubayy , United Arab Emirates , Ras Al Khaimah , Ras Al Khaymah , Kuwait , Woman , Chinese , Essam Farouk , Julphar Or Gulf Pharmaceutical Industries , , Image Credit , Gulf Pharmaceutical Industries , சீனா , சவுதி அரேபியா , துபாய் , ஒன்றுபட்டது அரபு அமீரகங்கள் , ராஸ் அல் கைமா , குவைத் , ஓமான் , சீன , படம் கடன் , வளைகுடா மருந்து தொழில்கள் ,
comparemela.com © 2020. All Rights Reserved.